These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27556837)

  • 1. Vedolizumab in Inflammatory Bowel Disease Associated with Autoimmune Liver Disease Pre- and Postliver Transplantation: A Case Series.
    Lim TY; Pavlidis P; Gulati S; Pirani T; Samaan M; Chung-Faye G; Dubois P; Irving P; Heneghan M; Hayee B
    Inflamm Bowel Dis; 2016 Oct; 22(10):E39-40. PubMed ID: 27556837
    [No Abstract]   [Full Text] [Related]  

  • 2. Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease.
    Christensen B; Micic D; Gibson PR; Yarur A; Bellaguarda E; Corsello P; Gaetano JN; Kinnucan J; Rao VL; Reddy S; Singh S; Pekow J; Rubin DT
    Aliment Pharmacol Ther; 2018 Mar; 47(6):753-762. PubMed ID: 29377235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vedolizumab is safe and effective in moderate-to-severe inflammatory bowel disease following liver transplantation.
    Wright AP; Fontana RJ; Stidham RW
    Liver Transpl; 2017 Jul; 23(7):968-971. PubMed ID: 28296011
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of vedolizumab as a treatment option for moderate to severe refractory ulcerative colitis in two patients after liver transplant due to primary sclerosing cholangitis.
    Olmedo Martín RV; Amo Trillo V; González Grande R; Jiménez Pérez M
    Rev Esp Enferm Dig; 2017 Sep; 109(9):659-662. PubMed ID: 28724302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: vedolizumab for the management of inflammatory bowel disease in patients after liver transplantation for primary sclerosing cholangitis.
    Hartery K; O'Reilly S; Houlihan D; Doherty G; Mulcahy H; Cullen G; Sheridan J
    Aliment Pharmacol Ther; 2017 Jan; 45(2):376-378. PubMed ID: 27933688
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor necrosis α treatment in primary sclerosing cholangitis associated inflammatory bowel disease after liver transplantation.
    Pavlidis P; Potts J; Barnabas A; Heaton N; Bjarnason I; Heneghan M; Hayee B
    Liver Transpl; 2015 Nov; 21(11):1455-6. PubMed ID: 26175058
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of vedolizumab in liver transplant recipients: A systematic review.
    Spadaccini M; Aghemo A; Caprioli F; Lleo A; Invernizzi F; Danese S; Donato MF
    United European Gastroenterol J; 2019 Aug; 7(7):875-880. PubMed ID: 31428411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Fleisher M; Marsal J; Lee SD; Frado LE; Parian A; Korelitz BI; Feagan BG
    Dig Dis Sci; 2018 Apr; 63(4):825-833. PubMed ID: 29484571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Ulcerative Colitis Using Vedolizumab After Liver Transplantation for Primary Sclerosing Cholangitis.
    Meszaros M; Pageaux GP; Altwegg R
    J Crohns Colitis; 2016 Feb; 10(2):236. PubMed ID: 26449788
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease.
    Pavlidis P; Graham J; Gulati S; Dubois P; Heneghan M; Joshi D; Hayee B
    Aliment Pharmacol Ther; 2018 May; 47(10):1422-1423. PubMed ID: 29676010
    [No Abstract]   [Full Text] [Related]  

  • 11. Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review.
    Chateau T; Bonovas S; Le Berre C; Mathieu N; Danese S; Peyrin-Biroulet L
    J Crohns Colitis; 2019 Dec; 13(12):1569-1577. PubMed ID: 31076751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients.
    Stephens J; Goldstein R; Crippin J; Husberg B; Holman M; Gonwa TA; Klintmalm G
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1122-3. PubMed ID: 7680144
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply.
    Christensen B; Gibson PR; Rubin DT
    Aliment Pharmacol Ther; 2018 May; 47(10):1423-1424. PubMed ID: 29676007
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver transplantation and inflammatory bowel disease.
    Papatheodoridis GV; Hamilton M; Rolles K; Burroughs AK
    J Hepatol; 1998 Jun; 28(6):1070-6. PubMed ID: 9672186
    [No Abstract]   [Full Text] [Related]  

  • 15. Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease.
    Paccou J; Nachury M; Duchemin C; Desreumaux P; Flipo RM; Pariente B
    Joint Bone Spine; 2019 Oct; 86(5):654-656. PubMed ID: 30711690
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.
    Wiesner RH
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):667-80. PubMed ID: 11492975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenges of liver transplantation in children with primary sclerosing cholangitis.
    Venkat VL; Ranganathan S; Sindhi R
    Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):289-94. PubMed ID: 25592492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerosing Cholangitis in Children and Adolescents.
    Mieli-Vergani G; Vergani D
    Clin Liver Dis; 2016 Feb; 20(1):99-111. PubMed ID: 26593293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
    Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
    EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for sclerosing cholangitis.
    Narumi S; Roberts JP; Emond JC; Lake J; Ascher NL
    Hepatology; 1995 Aug; 22(2):451-7. PubMed ID: 7635412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.